COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $972 | -50.1% | 260 | -8.8% | 0.00% | – |
| Q1 2023 | $1,949 | -80.8% | 285 | -77.8% | 0.00% | – |
| Q4 2022 | $10,177 | -21.7% | 1,285 | -3.2% | 0.00% | – |
| Q3 2022 | $13,000 | +44.4% | 1,328 | +3.3% | 0.00% | – |
| Q2 2022 | $9,000 | -79.5% | 1,285 | -61.8% | 0.00% | – |
| Q1 2022 | $44,000 | -27.9% | 3,368 | -12.3% | 0.00% | – |
| Q4 2021 | $61,000 | +10.9% | 3,841 | +11.6% | 0.00% | – |
| Q3 2021 | $55,000 | -26.7% | 3,441 | -36.3% | 0.00% | – |
| Q2 2021 | $75,000 | +82.9% | 5,406 | +90.4% | 0.00% | – |
| Q1 2021 | $41,000 | -16.3% | 2,840 | 0.0% | 0.00% | – |
| Q4 2020 | $49,000 | -5.8% | 2,840 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | +10.6% | 2,840 | +8.2% | 0.00% | – |
| Q2 2020 | $47,000 | – | 2,625 | +26150.0% | 0.00% | – |
| Q3 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |